An open-label, multicenter, expanded access study of imatinib mesylate in adult patients with GIST in adjuvant setting after R0-resection

Update Il y a 5 ans
Reference: EUCTR2008-003883-20

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To evaluate the safety and tolerability of imatinib as measured by rate and severity of adverse events.


Inclusion criteria

  • gastrointestinal stromal tumors - adjuvant treatment after surgical tumor resection